The report studies the U.S. Ketamine market from 2007 to 2015 and anticipates moderate growth from 2011 to 2016. Anesthesia drugs included in the report are propofol, midazolam, diazepam and more.
The U.S. general anesthesia market was worth approximately $2 billion in 2011 and should grow 4 percent. Anesthetic drugs account for 65 percent of the general anesthetic drug market.
More Articles on Anesthesia:
Dr. Robert Brooker of Sheridan Healthcare to Discuss Blood Conservation at ASA Meeting
Dr. Mark Romanoff Nominated as Physician of the Year Finalist
Anesthesiologist Updates for Oct. 1, 2014
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
